...
首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers
【24h】

Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers

机译:Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers

获取原文
获取原文并翻译 | 示例
           

摘要

Glioblastoma multiforme (GBM), the grade IV astrocytoma, is the most common and aggressive brain tumor in adults. Despite advances in medical management, the survival rate of GBM patients remains poor, suggesting that identification of GBM-specific targets for therapeutic development is urgently needed. Analysis of several glycan antigens on GBM cell lines revealed that eight of 11 GBM cell lines are positive for stage-specific embryonic antigen-4 (SSEA-4), and immunohistochemical staining confirmed that 38/55 (69) of human GBM specimens, but not normal brain tissue, were SSEA-4~+ and correlated with high-grade astrocytoma. In addition, an SSEA-4–specific mAb was found to induce complement-dependent cytotoxicity against SSEA-4~(hi) GBM cell lines in vitro and suppressed GBM tumor growth in mice. Because SSEA-4 is expressed on GBM and many other types of cancers, but not on normal cells, it could be a target for development of therapeutic antibodies and vaccines.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号